339 related articles for article (PubMed ID: 34133412)
41. Bilateral herpetic keratoconjunctivitis.
Souza PM; Holland EJ; Huang AJ
Ophthalmology; 2003 Mar; 110(3):493-6. PubMed ID: 12623810
[TBL] [Abstract][Full Text] [Related]
42. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA
Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
[TBL] [Abstract][Full Text] [Related]
43. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
44. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
Garcia DD; Farjo Q; Musch DC; Sugar A
Cornea; 2007 Sep; 26(8):930-4. PubMed ID: 17721290
[TBL] [Abstract][Full Text] [Related]
45. The treatment of HSV1 ocular infections using quantitative real-time PCR results.
Hlinomazová Z; Loukotová V; Horáčková M; Šerý O
Acta Ophthalmol; 2012 Aug; 90(5):456-60. PubMed ID: 20553233
[TBL] [Abstract][Full Text] [Related]
46. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
47. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
Barney NP; Foster CS
Cornea; 1994 May; 13(3):232-6. PubMed ID: 8033573
[TBL] [Abstract][Full Text] [Related]
48. The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections.
Sudesh S; Laibson PR
Curr Opin Ophthalmol; 1999 Aug; 10(4):230-3. PubMed ID: 10621528
[TBL] [Abstract][Full Text] [Related]
49. The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis.
Altay Y; Tamer S; Kaya AS; Balta O; Burcu A; Ornek F
Arq Bras Oftalmol; 2017; 80(1):41-45. PubMed ID: 28380101
[TBL] [Abstract][Full Text] [Related]
50. Update on management of herpes keratitis in children.
Revere K; Davidson SL
Curr Opin Ophthalmol; 2013 Jul; 24(4):343-7. PubMed ID: 23665524
[TBL] [Abstract][Full Text] [Related]
51. Management of herpes simplex virus stromal keratitis: an evidence-based review.
Knickelbein JE; Hendricks RL; Charukamnoetkanok P
Surv Ophthalmol; 2009; 54(2):226-34. PubMed ID: 19298901
[TBL] [Abstract][Full Text] [Related]
52. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
53. Stromal keratitis and anterior uveitis due to herpes simplex virus-2 in a young child.
Inoda S; Wakakura M; Hirata J; Nakazato N; Toyo-Oka Y
Jpn J Ophthalmol; 2001; 45(6):618-21. PubMed ID: 11754904
[TBL] [Abstract][Full Text] [Related]
54. Long term visual outcomes, graft survival and complications of deep anterior lamellar keratoplasty in patients with herpes simplex related corneal scarring.
Lyall DA; Tarafdar S; Gilhooly MJ; Roberts F; Ramaesh K
Br J Ophthalmol; 2012 Sep; 96(9):1200-3. PubMed ID: 22826552
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus bullous keratitis misdiagnosed as a case of pseudophakic bullous keratopathy with secondary glaucoma: an unusual presentation.
Athmanathan S; Sridhar MS; Anand R; Mandal AK; Rao GN
BMC Ophthalmol; 2001; 1():2. PubMed ID: 11472638
[TBL] [Abstract][Full Text] [Related]
56. Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis.
Dutt S; Acharya M; Gour A; Sapra N; Chauhan L; Mathur U
Indian J Ophthalmol; 2016 Apr; 64(4):292-5. PubMed ID: 27221681
[TBL] [Abstract][Full Text] [Related]
57. Commercial human 3D corneal epithelial equivalents for modeling epithelial infection in herpes keratitis.
Borodianskiy-Shteinberg T; Bisht P; Das B; Kinchington PR; Goldstein RS
Virology; 2024 Jul; 595():110096. PubMed ID: 38710129
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.
Alekseev O; Donovan K; Azizkhan-Clifford J
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):706-15. PubMed ID: 24370835
[TBL] [Abstract][Full Text] [Related]
59. Herpes Simplex Keratitis as a Complication of Pterygium Surgery.
Cui X; Qiu J; Huang F; Zhang C; Shao T; Wang Y
Am J Case Rep; 2024 Feb; 25():e942401. PubMed ID: 38400535
[TBL] [Abstract][Full Text] [Related]
60. Herpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin).
Khalili MR; Mehdizadeh M; Mehryar M
Cornea; 2009 Apr; 28(3):360-1. PubMed ID: 19387245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
